Your browser doesn't support javascript.
loading
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
Tan, Elaine S; Cao, Biwei; Kim, Jongphil; Al-Toubah, Taymeyah E; Mehta, Rutika; Centeno, Barbara A; Kim, Richard D.
Affiliation
  • Tan ES; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Cao B; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Kim J; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Al-Toubah TE; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Mehta R; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Centeno BA; Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Kim RD; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.
Cancer ; 127(8): 1293-1300, 2021 04 15.
Article in En | MEDLINE | ID: mdl-33289918

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Quinazolines / Biliary Tract Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Cholangiocarcinoma / Deoxycytidine Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Quinazolines / Biliary Tract Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Cholangiocarcinoma / Deoxycytidine Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2021 Type: Article